ArticleInternational journal of molecular sciences2022

A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus Disease.

Julie Zimmermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.